HealthEquity, Inc. (HQY): Price and Financial Metrics

HealthEquity, Inc. (HQY)

Today's Latest Price: $41.09 USD

2.80 (-6.38%)

Updated Apr 3 12:00am

Add HQY to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 9 in Medical - Health Insurance

See all "A" rated Strong Buy stocks

HQY Stock Summary

  • HQY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,062.02 -- higher than 97.15% of US-listed equities with positive expected earnings growth.
  • With a price/earnings ratio of 66.77, Healthequity Inc P/E ratio is greater than that of about 93.27% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 3,175.37%, Healthequity Inc's debt growth rate surpasses 98.75% of about US stocks.
  • Stocks that are quantitatively similar to HQY, based on their financial statements, market capitalization, and price volatility, are FEYE, YY, SMTC, SVMK, and CREE.
  • Visit HQY's SEC page to see the company's official filings. To visit the company's web site, go to
HQY Daily Price Range
HQY 52-Week Price Range

HQY Stock Price Chart More Charts

HQY Price/Volume Stats

Current price $41.09 52-week high $88.78
Prev. close $43.89 52-week low $34.40
Day low $40.55 Volume 618,700
Day high $45.37 Avg. volume 992,994
50-day MA $63.16 Dividend yield N/A
200-day MA $64.72 Market Cap 2.91B

HealthEquity, Inc. (HQY) Company Bio

HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.

HQY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for HQY, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Healthequity Inc ranked in the 60th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for Healthequity Inc ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 70. Its equity weight surpasses that of only 24.01% of free cash flow generating stocks in the Technology sector.
  • Its compound free cash flow growth rate, as measured over the past 5.01 years, is 0.6% -- higher than 85.91% of stocks in our DCF forecasting set.
  • HQY's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 5%; for context, that number is higher than 45.85% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HQY, try NCR, CCIHY, SLP, DTST, and AMKR.

HQY Latest News Stream

Event/TimeNews Detail
Loading, please wait...

HQY Latest Social Stream

Loading social stream, please wait...

View Full HQY Social Stream

HQY Price Returns

1-mo -34.61%
3-mo -43.18%
6-mo -21.82%
1-year -47.14%
3-year -4.77%
5-year 71.21%
YTD -44.53%
2019 24.17%
2018 27.84%
2017 15.15%
2016 61.63%
2015 -1.49%

Continue Researching HQY

Want to see what other sources are saying about Healthequity Inc's financials and stock price? Try the links below:

Healthequity Inc (HQY) Stock Price | Nasdaq
Healthequity Inc (HQY) Stock Quote, History and News - Yahoo Finance
Healthequity Inc (HQY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.4069 seconds.